A detailed history of Bank Of America Corp transactions in Surmodics Inc stock. As of the latest transaction made, Bank Of America Corp holds 21,262 shares of SRDX stock, worth $841,124. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,262
Previous 20,060 5.99%
Holding current value
$841,124
Previous $843,000 2.25%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$38.47 - $42.24 $46,240 - $50,772
1,202 Added 5.99%
21,262 $824,000
Q2 2024

Aug 14, 2024

SELL
$25.39 - $42.1 $7.62 Million - $12.6 Million
-300,300 Reduced 93.74%
20,060 $843,000
Q1 2024

May 15, 2024

BUY
$27.44 - $35.56 $1.9 Million - $2.46 Million
69,206 Added 27.56%
320,360 $9.4 Million
Q4 2023

Feb 14, 2024

BUY
$28.47 - $38.49 $6.63 Million - $8.96 Million
232,792 Added 1267.79%
251,154 $9.13 Million
Q2 2023

Aug 14, 2023

SELL
$17.67 - $31.31 $115,261 - $204,235
-6,523 Reduced 26.21%
18,362 $574,000
Q1 2023

May 12, 2023

BUY
$17.13 - $38.52 $234,252 - $526,761
13,675 Added 121.99%
24,885 $566,000
Q4 2022

Feb 10, 2023

BUY
$29.44 - $37.31 $161,978 - $205,279
5,502 Added 96.39%
11,210 $382,000
Q3 2022

Nov 14, 2022

SELL
$28.84 - $38.92 $76,483 - $103,215
-2,652 Reduced 31.72%
5,708 $174,000
Q2 2022

Aug 12, 2022

SELL
$33.25 - $45.11 $253,065 - $343,332
-7,611 Reduced 47.66%
8,360 $311,000
Q1 2022

May 16, 2022

SELL
$40.68 - $49.72 $321,575 - $393,036
-7,905 Reduced 33.11%
15,971 $723,000
Q4 2021

Feb 08, 2022

BUY
$43.21 - $57.6 $368,408 - $491,097
8,526 Added 55.54%
23,876 $1.15 Million
Q3 2021

Nov 15, 2021

BUY
$52.8 - $60.32 $181,368 - $207,199
3,435 Added 28.83%
15,350 $853,000
Q2 2021

Sep 13, 2021

BUY
$51.29 - $59.15 $611,120 - $704,772
11,915 New
11,915 $646,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $554M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.